JW Life Science Corp
KRX:234080
JW Life Science Corp
KRX:234080
Price:
12 780
KRW
2.4%
Market Closed
Market Cap:
₩202.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
JW Life Science Corp
KRX:234080
|
KR |
|
Atlantic American Corp
NASDAQ:AAME
|
US |
|
T
|
Tony G Co-Investment Holdings Ltd
CNSX:TONY
|
CA |
|
F
|
Fermi Inc
NASDAQ:FRMI
|
US |
|
Gujarat Sidhee Cement Ltd
NSE:GSCLCEMENT
|
IN |
|
BOC Hong Kong Holdings Ltd
HKEX:2388
|
HK |
|
Payright Ltd
ASX:PYR
|
AU |
|
G
|
Guangdong Xinbao Electrical Appliances Holdings Co Ltd
SZSE:002705
|
CN |
|
Minna Padi Investama Sekuritas Tbk PT
IDX:PADI
|
ID |
Multiples-Based Value
The Multiples-Based Value of one
JW Life Science Corp
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 12 780 KRW,
JW Life Science Corp
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JW Life Science Corp Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
JW Life Science Corp Competitors
JW Life Science Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
JW Life Science Corp
KRX:234080
|
197.9B KRW | 0.8 | 4.2 | 3.8 | 5.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.6 | 43 | 29 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP | 5.3 | 30.4 | 16.8 | 23.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.5 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.7B GBP | 2.7 | 15.5 | 8.4 | 10.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
